about us | newsletter | contact | archive | members area
Nadia Crisan, McGuire Woods Romania
For many of you, the subject of the cadastre and its absence was a barrier in their deve»
  News:      POLITICS   |   ECONOMICS   |   ENERGY   |   INVESTMENTS   |   APPOINTMENTS   |   GREEN   |   INFRASTRUCTURE   |   REAL ESTATE   |   AGRIBUSINESS   |   DRIVING   |   CITY LIFE   |   EVENTS   |

Cegedim: Pharmaceutical segment in Romania loses 4 per cent in Q1 and reaches 669 million Euro

The pharmaceutical products sales in Romania, reflected in the distribution price decreased by four per cent in Q1 this year compared to the same interval of 2013 and reached a total value of 668.8 million Euro, under expectations, according to Cegedim data.

2014-05-20 10:54:21

Petru Craciun, general manager of Cegedim states that the slightly warmer winter is accountable for the results. For 2014, in the context of a yet not updated subsidized medicine product list, the estimates take into account a decrease from 2.7 per cent to -0.3 per cent in local currency for the market. The decrease in lei for the Q1 was estimated at 1.5 per cent, to 3 billion lei.

In Q1, the pharmaceutical retail segment for Rx products reached 471.7 million Euro (2.12 billion lei), 2.2 per cent less while OTCs accounted for 109 million Euro (490 million lei), increased value of 2.4 per cent. The overall retail decreased in Q1 with 3.9 per cent and reached 580.6 million Euro, while other distribution channels such as hospitals increased with 4.9 per cent to 88.2 million Euro.

The company ranking for this market is led by Servier with 673.3 million lei and increase of 5.8 per cent, Pfizer with 600.1 million lei and 5.1 per cent increase, GlaxoSmithKline (510,3 million lei and 4,4 per cent), Ranbaxy (464,6 million lei and 4 per cent), Merck&Co (450,5 million lei and 3,8 per cent), AstraZeneca (440,3 million lei and 3,8 per cent) and Krka (316 million lei and 2,7 per cent).

They are followed by Johnson&Johnson, Antibiotice, Abbvie, Teva, Menarini, Bayer, Bristol Myers Squibb, Alvogen, Actavis and Eli Lilly, with market shares between 2.5 per cent and 1.6 per cent.



COMMENTS
There are 0 comments:

 
ADD A COMMENT
 
Name
Email
Comment
Validation Code
   
 
 

0 Comments  |  1741 Views
Daily Info
IBA/European Regional Forum - Law Firm Management Roadshow/Roundtable, March 19 2015, Bucharest

Following the success of the 2013 M&A Roadshow, the IBA (International Bar Association) European Regional Forum organizes another thematic seminar in Romania on March 19th, th...

Investments estimated at 45.45 billion Euro for General Transport Master Plan

The Romanian government passed a memorandum regarding Romania General Transport Master Plan, a document establishing that the total investments needed will reach up to 45.45 b...

European Commission opens macroeconomic imbalance procedure for Romania

The European Commission has decided to start the macroeconomic imbalance procedure (MIP) for Romania (and Portugal), two of the 16 countries identified in November 2014 as rec...

OTP Consulting Romania gives the start of a wide project of supporting entrepreneurship

OTP Consulting Romania, member of OTP Group, together with University Politehnica of Bucharest, the most prestigious technical university from Romania, announces the launch of...

SAMA and Ultratest rebrand as MedLife-Sama

Medical services operator MedLife announced the completion of purchase of the majority stake of 55 per cent for the group of companies Sama and Ultratest, with locations in So...

 
 
   
advertising

advertising

advertising

advertising

advertising

More on News
EC Corina Cretu offers mediation between Romania, Hungary on cross-border program

European Commissioner for Regional Policy Corina Cretu discussed the Interreg V-A Romania-Hungary cross-border cooperation programme in January with Romanian Foreign Minist...

Competition Council to apply the first fines for noncompliance

In mid-January, Romania's Competition Council (CC) fined both Avenir Telecom and Euronet Services, as well as the Professional Football League (LPF) with fines totalling 70...

Romania to export electricity of 250 million Euro in 2014

In early January, the European Network of Transmission System Operators for Electricity (ENTSO-E) announced that Romania exported about 7.28 TWh of electricity, worth about...

Two million-Euro grain processing plant in Braila

Romanian-based Rodbun Group, specialized in the distribution of seeds, pesticides and fertilizers, will invest two million Euro in Tichilesti, Braila county, to build one o...

EC finances the Cernavoda-Constanta section of Sun Highway

The European Commission decided recently to cover construction costs for the Cernavoda-Constanta section of the A2 "Sun Highway", initially financed by the Romanian state t...

Eco-Rom Ambalaje registers four per cent collection growth in the first nine months of last year

Eco-Rom Ambalaje, founded to fulfil the recycling obligations for packaging waste incumbent on producers that deal with packaged products, collected and recycled 265,986 to...

AFI Europe completed the third office building from AFI Park with 20 million Euro investment

AFI Europe Romania reports it completed the third office building of AFI Park with 20 million Euro worth of investment, with major tenants Endava and Telus International